header logo
Vallibel FD
vallible LE
Latest
Denmark, Norway and Iceland suspend use of AstraZeneca COVID vaccine
Denmark, Norway and Iceland suspend use of AstraZeneca COVID vaccine
Mobitel inner 1278

COPENHAGEN, March 11 (Reuters) - Health authorities in Denmark, Norway and Iceland on Thursday suspended the use of AstraZeneca’s COVID-19 vaccine shots following reports of the formation of blood clots in some people who had been vaccinated.

 

Austria earlier stopped using a batch of AstraZeneca shots while investigating a death from coagulation disorders and an illness from a pulmonary embolism.

 

Still, the European medicine regulator EMA said the vaccine’s benefits outweighed its risks and could continue to be administered.

 

Europe is struggling to speed up a vaccine rollout after delivery delays from Pfizer and AstraZeneca, even as a spike in cases amid a more contagious virus variant has triggered fresh lockdowns in countries like Italy and France.

 

Denmark suspended the shots for two weeks after a 60-year-old woman, who was given an AstraZeneca shot from the same batch used in Austria, formed a blood clot and died, Danish health authorities said.

 

Their response was also prompted by reports “of possible serious side effects” from other European countries.

 

“It is currently not possible to conclude whether there is a link. We are acting early, it needs to be thoroughly investigated,” Health Minister Magnus Heunicke said on Twitter.

 

The vaccine would be suspended for 14 days in Denmark.

 

“This is a cautionary decision,” Geir Bukholm, director of infection prevention and control at the Norwegian Institute of Public Health (FHI), told a news conference.

 

FHI did not say how long the suspension would last.

 

“We ... await information to see if there is a link between the vaccination and this case with a blood clot,” Bukholm said.

 

Iceland on Thursday suspended jabs with the vaccine as it awaited the results of an investigation by the EMA. Italy, also on Thursday, said it would suspend use of an AstraZeneca batch different to the one used in Austria.

 

Some health experts said there was little evidence to suggest the AstraZeneca vaccine should not be administered and that the cases of blood clots corresponded with the rate of such cases in the general population.

 

“The problem with spontaneous reports of suspected adverse reactions to a vaccine are the enormous difficulty of distinguishing a causal effect from a coincidence,” Stephen Evans, professor of pharmacoepidemiology at the London School of Hygiene & Tropical Medicine, told Reuters.

 

Evans added that the COVID-19 disease was very strongly associated with blood clotting.

 

Phil Bryan, head of the UK Medicines and Healthcare Products Regulatory Agency (MHRA) said reports of blood clots so far didn’t exceed what would have occurred naturally in the vaccinated population.

 

“Available evidence does not confirm that the vaccine is the cause,” he said.

 

More than 11 million doses of AstraZeneca’s vaccine have so far been administered across the UK.

 

AstraZeneca told Reuters in a written statement the safety of its vaccine had been extensively studied in human trials and peer-reviewed data confirmed it was generally well tolerated.

 

The drugmaker said this week there had been “no confirmed serious adverse events associated with the vaccine”. It said it was in contact with Austrian authorities and would fully support their investigation.

 

The European Union’s drug regulator, the EMA, said on Wednesday there was no evidence so far linking AstraZeneca to the two cases in Austria.

 

It said the number of thromboembolic events - marked by the formation of blood clots - in people who have received the AstraZeneca vaccine was no higher than that seen in the general population, with 22 cases reported among the 3 million people who have received the shot as of March 9.

 

EMA said it understood the decision by Denmark and Norway was taken as a precaution.

 

Four other countries - Estonia, Lithuania, Luxembourg and Latvia - have stopped inoculations from the batch while investigations continue, the EMA said.

 

The batch of 1 million doses went to 17 EU countries.

 

Swedish authorities said they did not find sufficient evidence to stop vaccination with AstraZeneca’s jab.

 

“There is nothing to indicate that the vaccine causes this type of blood clots,” Veronica Arthurson, head of drug safety at the Swedish Medical Products Agency, told a news conference.

 

The Danish Medicines Agency said it had launched an investigation into the vaccine together with corresponding agencies in other EU countries and the EMA.

 

So far, 138,148 Danes have received a shot with AstraZeneca’s vaccine in a country of 5.8 million. The Nordic country, which also uses vaccines from Pfizer-BioNTech and Moderna, is set to receive 2.6 million doses from AstraZeneca over the coming months.

 

Denmark’s Health Authority said the final date for when it expects all Danes to have been fully vaccinated would be pushed back by four weeks to Aug. 15.

 

Spain on Thursday said it had not registered any cases of blood clots related to AstraZeneca’s vaccine so far and would continue administering the shots.

 

The EU’s drugs regulator on Thursday approved Johnson & Johnson’s single dose COVID-19 vaccine.

 

Source: Reuters 

 

-Agencies

 

 

 

Disclaimer: All the comments will be moderated by the AD editorial. Abstain from posting comments that are obscene, defamatory or slanderous. Please avoid outside hyperlinks inside the comment and avoid typing all capitalized comments. Help us delete comments that do not follow these guidelines by flagging them (mouse over a comment and click the flag icon on the right side). Do use these forums to voice your opinions and create healthy discourse.

Comments

0
Comments are disabled

Note: Due to legal constraints, the Ada Derana Editorial team has taken a decision to disable comments on all articles concerning ongoing court procedures.

MostRead
Mobitel 1278
VideoStories
"Turn budget promises into reality" Sajith says development projects must deliver tangible benefits

"Turn budget promises into reality" Sajith says development projects must deliver tangible benefits

“SL has reached a macro-stabilisation milestone” Govt. defends its investment and procurement policy

“SL has reached a macro-stabilisation milestone” Govt. defends its investment and procurement policy

Another bankruptcy risk?  Opposition questions feasibility of Rs. 2 trillion capital spending target

Another bankruptcy risk? Opposition questions feasibility of Rs. 2 trillion capital spending target

Global Lankan Entrepreneur Club launched;  Dilith Jayaweera unveils global business platform

Global Lankan Entrepreneur Club launched; Dilith Jayaweera unveils global business platform

Heavy rains expected in Northern and Eastern areas  - Met Department warns

Heavy rains expected in Northern and Eastern areas - Met Department warns

Van driver arrested after collision with motorcycle  kills father and son in Chavakachcheri

Van driver arrested after collision with motorcycle kills father and son in Chavakachcheri

Laugfs Gas CEO apologises to consumers  over LP gas shortage, explains price hike

Laugfs Gas CEO apologises to consumers over LP gas shortage, explains price hike

Policy inconsistencies hinder investor confidence   - Tax specialist says at post-budget forum

Policy inconsistencies hinder investor confidence - Tax specialist says at post-budget forum

SEC backs key 2027 Budget proposals  to strengthen capital market

SEC backs key 2027 Budget proposals to strengthen capital market

‘AI Center of Excellence’ aims to develop industry-specific solutions-Dy Minister of Digital Economy

‘AI Center of Excellence’ aims to develop industry-specific solutions-Dy Minister of Digital Economy

JVP marks 37th November Heroes’ Day  under President’s patronage today

JVP marks 37th November Heroes’ Day under President’s patronage today

Debate on Second Reading of 2027 Budget  gets underway in Parliament

Debate on Second Reading of 2027 Budget gets underway in Parliament

SC clears PSTA Bill for passage with simple majority; Four amendments required at Committee Stage

SC clears PSTA Bill for passage with simple majority; Four amendments required at Committee Stage

 Rajangane Saddharathana involved inclash at A’pura protest siteThree monks takeninto police custody

Rajangane Saddharathana involved inclash at A’pura protest siteThree monks takeninto police custody

 2027 Budget deficit projected at Rs.1.75 trillion;Tax-free income threshold increased to Rs.162,500

2027 Budget deficit projected at Rs.1.75 trillion;Tax-free income threshold increased to Rs.162,500

Lassana Flora